ロード中...
2018 Synaptic vesicle 2 receptors as a novel targets for neuroendocrine cancer therapy
OBJECTIVES/SPECIFIC AIMS: (1) To delineate the function of the heavy-chain receptor binding domain (HCR), a portion of botulinum neurotoxin type A (BoNT/A) and synaptic vesicle 2 (SV2) signaling pathway, which provide a novel multipurpose biologic with potential clinical applications in tumor detect...
保存先:
| 出版年: | J Clin Transl Sci |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cambridge University Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6799207/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/cts.2018.125 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|